Detalhe da pesquisa
1.
Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose.
Retrovirology
; 11: 8, 2014 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24444350
2.
Novel biopanning strategy to identify epitopes associated with vaccine protection.
J Virol
; 87(8): 4403-16, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23388727
3.
Live-virus exposure of vaccine-protected macaques alters the anti-HIV-1 antibody repertoire in the absence of viremia.
Retrovirology
; 10: 63, 2013 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23800339
4.
Development of a tier 1 R5 clade C simian-human immunodeficiency virus as a tool to test neutralizing antibody-based immunoprophylaxis.
J Med Primatol
; 40(2): 120-8, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21044092
5.
Relative transmissibility of an R5 clade C simian-human immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routes.
J Infect Dis
; 201(8): 1155-63, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20214475
6.
Laboratory-Generated DNA Can Cause Anomalous Pathogen Diagnostic Test Results.
Microbiol Spectr
; 9(2): e0031321, 2021 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34523989
7.
Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection.
J Virol
; 83(3): 1422-32, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19019970
8.
SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys.
Retrovirology
; 5: 94, 2008 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-18928523
9.
Efficacy of a multigenic protein vaccine containing multimeric HIV gp160 against heterologous SHIV clade C challenges.
AIDS
; 21(14): 1841-8, 2007 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-17721091
10.
Dendritic cell-based vaccine strategy against human immunodeficiency virus clade C: skewing the immune response toward a helper T cell type 2 profile.
Viral Immunol
; 20(1): 160-9, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17425430
11.
Anomalous COVID-19 tests hinder researchers.
Science
; 371(6526): 244-245, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446547
12.
Schistosoma mansoni infection promotes SHIV clade C replication in rhesus macaques.
AIDS
; 19(16): 1793-7, 2005 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-16227786
13.
Neutralizing antibodies as a potential secondary protective mechanism during chronic SHIV infection in CD8+ T-cell-depleted macaques.
AIDS
; 16(6): 829-38, 2002 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-11919484
14.
Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques.
AIDS
; 17(3): 301-9, 2003 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-12556683
15.
Quantitation of simian cytokine and beta-chemokine mRNAs, using real-time reverse transcriptase-polymerase chain reaction: variations in expression during chronic primate lentivirus infection.
AIDS Res Hum Retroviruses
; 18(9): 627-39, 2002 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-12079558
16.
Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus.
Vaccine
; 32(48): 6527-36, 2014 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25245933
17.
High-level, lasting antiviral immunity induced by a bimodal AIDS vaccine and boosted by live-virus exposure: prevention of viremia.
AIDS
; 26(2): 149-55, 2012 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21941166
18.
Vaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protection.
PLoS One
; 6(7): e22010, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21799765
19.
Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges.
Vaccine
; 29(34): 5611-22, 2011 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-21693155
20.
Bimodal AIDS vaccine approach: induction of cellular as well as humoral immunity can protect from systemic infection.
Vaccine
; 28 Suppl 2: B25-31, 2010 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20510739